Purdue Pharma bankruptcy plan that shields Sackler family faces Supreme Court review

The U.S. Supreme Court will hear oral arguments Monday about the legality of a $6 billion bankruptcy agreement for Purdue Pharma, the manufacturer of OxyContin. While many families of victims support the deal, which would fulfill financial settlements, it would shield the powerful Sackler family from thousands of potential lawsuits. CBS News' Jan Crawford reports.

Each weekday morning, "CBS Mornings” co-hosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.

Subscribe to “CBS Mornings” on YouTube: https://www.youtube.com/CBSMornings
Watch CBS News: http://cbsn.ws/1PlLpZ7c
Download the CBS News app: http://cbsn.ws/1Xb1WC8
Follow "CBS Mornings" on Instagram: https://bit.ly/3A13OqA
Like "CBS Mornings" on Facebook: https://bit.ly/3tpOx00
Follow "CBS Mornings" on Twitter: https://bit.ly/38QQp8B
Subscribe to our newsletter: http://cbsn.ws/1RqHw7T​
Try Paramount+ free: https://bit.ly/2OiW1kZ

For video licensing inquiries, contact: licensing@veritone.com

Видео Purdue Pharma bankruptcy plan that shields Sackler family faces Supreme Court review канала CBS Mornings